Legal Representation
Attorney
Andrea P. Nguyen
USPTO Deadlines
Next Deadline
1953 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20250422)
Due Date
April 22, 2031
Grace Period Ends
October 22, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 30, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Nov 10, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Nov 10, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Jul 22, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jul 11, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Jun 24, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jun 24, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Apr 22, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 22, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 4, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 4, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 11, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 11, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 11, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 11, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 11, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Feb 11, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 22, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 22, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 22, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 30, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 30, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 17, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Jul 29, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Jul 29, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jul 2, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jul 1, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 27, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 30, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jan 26, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 25, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 042
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the field of pharmacy; consultancy pertaining to pharmacology; medical research laboratory services; medical research laboratory services; scientific research services for medical purposes; medicine research; scientific analysis and evaluation of medical product development; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testing, inspection and research of medical products; consultancy in the field of testing, inspection, research of medical products; pharmaceutical product evaluation; medical and pharmacological research services; consulting services in the fields of medical research laboratory testing; scientific research in the fields of medicine and health and pharmacology; industrial research in the fields of medicine and health and pharmacology; research in the fields of medicine and surgery and specimen analysis; medical research
Class 044
Medical and health assessment services relating to DNA, genetics and genetic testing; telemedicine services; medical and health care clinic services; medical and health care services; conducting of medical examinations; medical examination services; medical care; medical clinic services; medical information; providing information in the field of medicine; medical screening; provision of information relating to medicine
Additional Information
Design Mark
The mark consists of "BIOSOLVIX" below the Korean characters that transliterate to "BIOSOLVIX".
Other
The non-Latin characters in the mark transliterate to "BIOSOLVIX" and this has no meaning in a foreign language.
Classification
International Classes
042
044